ASTERDMNSEAster DM Healthcare Limited· Healthcare ServicesHighNeutral
Announced Thu, 6 Nov, 2025 · 17:44 IST

Q2 revenue rises 10%, profit rises 14%; Anoop Moopen resigns

ASTERDM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹689.00
prior close
₹689.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.2%+0.7% vs market
Hospital peers, median of 20sector-0.1%+0.5% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Smallcap 250 and 0.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-1.4
15m
-1.4
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4-0.2+0.7-0.1+0.5
Next day
-1.0-0.2-0.8-1.5+0.5
2d
-1.7-0.4-1.3-2.2+0.4
3d
-1.7+0.3-2.1-2.3+0.6
4d
-2.2-0.1-2.1-2.7+0.5
5d
-1.6+0.1-1.7-2.8+1.3
1w
-1.6-0.2-1.4-3.0+1.4
15d
-3.5-1.9-1.5-2.7-0.8
1m
-10.0-5.5-4.5-5.1-4.9
2m
-10.0-1.4-8.6-6.2-3.8
3m
-16.9-4.6-12.3-11.0-6.0
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved unaudited Q2 and half-year results. Consolidated operating revenue rose 10.2% year on year to INR 1,197.21 crore, while profit attributable to owners rose 13.6% to INR 110.00 crore; EPS was INR 2.13. Half-year cash generated from operations rose 58.3% to INR 319.20 crore. The auditor's limited review found no material issue. Exceptional merger and acquisition costs were INR 4.75 crore. Director Anoop Moopen also resigned.

Likely market impact

Positive earnings and cash flow may support the stock, though growth was moderate. Anoop Moopen's exit creates uncertainty over board continuity.